Public Market Listing
688506SSE STAR Market
Live quotes, historical charts, and market capitalization for Sichuan Baili Pharmaceutical are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(9 total)
9Total Assets
0Approved
3Phase 3 / Filed
6Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | EGFR + HER3Antibody–drug conjugate | Non-Small Cell Lung CancerBreast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Phase 3 | HER2Antibody–drug conjugate | Non-Small Cell Lung Cancer | |
| Phase 3 | EGFR + HER3Multispecific antibody | Non-Small Cell Lung Cancer | |
| Phase 2 | Undisclosed / early pipelineAntibody–drug conjugate | Non-Small Cell Lung Cancer | |
| Phase 2 | PD-1 x CTLA-4Multispecific antibody | Non-Small Cell Lung Cancer | |
| Phase 1/2 | TROP2Antibody–drug conjugate | Non-Small Cell Lung Cancer | |
| Phase 1/2 | ROR1 (plus T-cell engaging costimulatory components)Multispecific antibody | Acute Myeloid Leukemia | |
| Phase 1 | Undisclosed / early pipelineAntibody–drug conjugate | Non-Small Cell Lung Cancer | |
| Phase 1 | CD3 x tumor antigen x immune checkpoint (multi-specific)Monoclonal antibody | Non-Small Cell Lung Cancer |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.